Breaking News

FDA Ignores Medical Board and Approves Painkiller with Potential of Abuse
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

The FDA has totally ignored the 11-2 disapproval of its medical advisory board and proceeded to approve Zohydro, a drug, which even during tests compelled one of the test subjects to commit suicide from overdosing and hoarding the drug. Zohydro is alleged to contain 5-10 times more of hydrocodon than Vicodin, and the extended release opiate is undiluted.

Significantly, it also does not contain the gel, now standard in OxyContin, that prevents the tablets from being crushed and snorted.

  
What
Where


During the December hearing on the drug last year, Avi Israel, the dad of a 20-year-old who committed suicide after hydrocodone addiction, said, “If you approve this pill, you surely will be signing a death sentence for thousands of people, especially young kids.”

But that was the personal opinion of a father who lost his son to painkiller addiction.

The FDA’s advisory board, however, was of the same opinion, and ruled 11-2 against approving the drug.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




One of the main reasons for going against approval of the drug, from the point of the advisory board, was that Zohydro did not dilute its opiate with acetaminophen, but, like OxyContin, provided the undiluted form.

The medical advisers warned that this could lead to greater possibility of addiction and abuse.



But that is probably the personal 11-2 opinion of the advisory board to not approve a money-making machine.

The FDA knows better and has gone on to approve the drug.

Liscinsky, the FDA spokesperson admitted that out of the 575 test subjects given Zohydro, 5 had died. Out of the first four deaths, one was suicide, another was from drug toxicity from other painkillers (not Zohydro), and one death was an “apparent suicide” by a patient who “hoarded study medication” and died a year after the study was over from an overdose.

However, be ready to now buy Zohydro over the counter, as the FDA has approved it.

Licinsky told Mother Jones, the publication, “FDA has concluded that the benefits of Zohydro ER outweigh its risks …”



 

RELEVANT JOBS

Associate Attorney

USA-CA-Sacramento

Qualification Requirements: Candidate must possess the requisite knowledge, skills and capability...

Apply now

Patent Paralegal

USA-TX-Austin

Boutique patent firm seeks experienced patent paralegal to support a small group of attorneys. This ...

Apply now

Staff Accountant

USA-CA-San Francisco

Levin Simes Abrams LLP has an immediate opening for a Staff Accountant to join our team and work clo...

Apply now

Attorney with some Unlawful Detainer experience preferred

USA-CA-Oakland

Oakland based law office has an opening for an Unlawful Detainer Attorney This is a temporary to ...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Intellectual Property Attorney

USA-CA-Los Angeles

Los Angeles office of a BCG Attorney Search Top Ranked Law Firm seeks an intellectual property attor...

Apply Now

Electrical Engineering, Computer Science/Engineering Associate Attorney

USA-IL-Chicago

Chicago office of a BCG Attorney Search Top Ranked Law Firm seeks electrical engineering, computer s...

Apply Now

Attorney

USA-FL-Jacksonville

Jacksonville office of a BCG Attorney Search Top Ranked Law Firm seeks an attorney with 4-20 years o...

Apply Now

SEARCH IN ARCHIVE

To Top